The limited storage capacity at the transmitters of a molecular communication (MC) system can affect the system's performance. One of the reasons for this limitation is the size restriction of the transmitter, which the storage must be replenished so that the transmitter has enough molecules for future transmission. This paper proposes a biologically inspired transmitter model based on neurons for MC whose storage charging and discharging follow differential equations. The proposed transmitter opens its outlet for a specific time in each time frame to exponentially release a portion of stored molecules to code bit-1 and remains silent to code bit-0. We analyze our model based on different transmission parameters. These parameters are the symbol duration, the release time duration, the storage capacity, and the release and replenishment rate of the storage. We find that the storage outlet must be open for a certain period within the time slot duration in order to improve the performance of the proposed system. Additionally, we demonstrate that determining the effect of storage capacity size can be important for practical MC due to the significant differences between the ideal transmitter and the proposed one, which have a limited size. We show that increases in the transmitter storage size can improve the system performance. As a result, taking a closer look at these practical transmitters is essential to solving the problems and challenges of molecular communication systems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/TNB.2022.3179317 | DOI Listing |
Sci Rep
January 2025
Department of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia.
Extracellular vesicles (EVs) are nanosized lipid bilayer particles released by various cellular organisms that carry an array of bioactive molecules. EVs have diagnostic potential, as they play a role in intercellular interspecies communication, and could be applied in drug delivery. In contrast to mammalian cell-derived EVs, the study of EVs from bacteria, particularly Gram-positive bacteria, received less research attention.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Emergency, the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.
Hepatocellular carcinoma (HCC) is a predominant cause of cancer-related mortality globally, noted for its propensity towards late-stage diagnosis and scarcity of effective treatment modalities. The process of metabolic reprogramming, with a specific emphasis on lipid metabolism, is instrumental in the progression of HCC. Nevertheless, the precise mechanisms through which lipid metabolism impacts HCC and its viability as a therapeutic target have yet to be fully elucidated.
View Article and Find Full Text PDFBiochim Biophys Acta Mol Cell Res
January 2025
Designing Future Health Initiative, Center for Promotion of Innovation Strategy, Head Office of Enterprise Partnerships, Tohoku University, Miyagi 980-8579, Japan.
Proteasome-dependent protein degradation and the digestion of peptides by aminopeptidases are essential for myogenesis. Methionine aminopeptidases (MetAPs) are uniquely involved in, both, the proteasomal degradation of proteins and in the regulation of translation (via involvement in post-translational modification). Suppressing MetAP1 and MetAP2 expression inhibits the myogenic differentiation of C2C12 myoblasts.
View Article and Find Full Text PDFMol Biol Rep
January 2025
Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016, India.
Background: Exosomes are extracellular vesicles released by cells that mediate intercellular communication and actively participate in cancer progression, metastasis, and regulation of immune response within the tumour microenvironment. Inhibiting exosome release from cancer cells could be employed as a therapeutic against cancer.
Methods And Results: In the present study, we have studied the effects of Acorus calamus in inhibiting exosome secretion via targetting Rab27a and neutral sphingomyelinase 2 (nSMase2) in HER2-positive (MDA-MB-453), hormone receptor-positive (MCF-7) and triple-negative breast cancer (MDA-MB-231) cells.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!